Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.69 |
| ▸ | NPC1 | O15118 | 4/20 | 0.69 |
| ▸ | BCHE | P06276 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | AR | P10275 | 4/20 | 0.62 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 4/20 | 0.59 |
| ▸ | TXN | P10599 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1131294 | 0.99 | RAB9A (0.68) | RAB9ANPC1BCHEALDH1A1AR | |
| SCHEMBL1131196 | 0.99 | RAB9A (0.68) | RAB9ANPC1BCHEALDH1A1AR | |
| SCHEMBL1130695 | 0.97 | RAB9A (0.69) | RAB9ANPC1BCHEALDH1A1AR | |
| SCHEMBL14304932 | 0.88 | BCHE (0.86) | RAB9ANPC1BCHEALDH1A1AR | |
| SCHEMBL14303261 | 0.86 | BCHE (0.83) | RAB9ANPC1BCHEALDH1A1AR | |
| SCHEMBL6141660 | 0.86 | BCHE (0.83) | RAB9ANPC1BCHEALDH1A1AR | |
| SCHEMBL14303260 | 0.86 | BCHE (0.83) | RAB9ANPC1BCHEALDH1A1AR | |
| SCHEMBL14304381 | 0.86 | BCHE (0.83) | RAB9ANPC1BCHEALDH1A1AR | |
| SCHEMBL14304387 | 0.86 | BCHE (0.83) | RAB9ANPC1BCHEALDH1A1AR | |
| Bromide SCHEMBL5084026 | 0.85 | BCHE (0.80) | RAB9ANPC1BCHEALDH1A1AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8932976-B2 | Preparation of catalyst for bisphenols production | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-01-13 | — | — | US | disclosed |
| EP-2158040-B1 | PREPARATION OF CATALYST FOR BISPHENOLS PRODUCTION | DOW GLOBAL TECHNOLOGIES INC (US) | 2011-02-16 | — | — | EP | disclosed |
| US-20100152028-A1 | PREPARATION OF CATALYST FOR BISPHENOLS PRODUCTION | DOW GLOBAL TECHNOLOGIES LLC | 2010-06-17 | — | — | US | disclosed |
| EP-2158040-A1 | PREPARATION OF CATALYST FOR BISPHENOLS PRODUCTION | Dow Global Technologies Inc. (US) | 2010-03-03 | — | — | EP | disclosed |
| WO-2008157025-A1 | PREPARATION OF CATALYST FOR BISPHENOLS PRODUCTION | DOW GLOBAL TECHNOLOGIES INC. (US) | 2008-12-24 | — | — | WO | disclosed |
| US-6995294-B2 | Method for producing bisphenol catalysts and bisphenols | GENERAL ELECTRIC COMPANY (US) | 2006-02-07 | — | — | US | disclosed |
| US-6992228-B2 | Method for producing bisphenol catalysts and bisphenols | GENERAL ELECTRIC COMPANY (US) | 2006-01-31 | — | — | US | disclosed |
| US-20050090696-A1 | Method for producing bisphenol catalysts and bisphenols | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2005-04-28 | — | — | US | disclosed |
| US-20050090697-A1 | Method for producing bisphenol catalysts and bisphenols | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2005-04-28 | — | — | US | disclosed |
| US-6884894-B2 | Method for producing bisphenol catalysts and bisphenols | GENERAL ELECTRIC COMPANY (US) | 2005-04-26 | — | — | US | disclosed |
| US-6872860-B1 | Method for producing bisphenol catalysts and bisphenols | GENERAL ELECTRIC COMPANY (US) | 2005-03-29 | — | — | US | disclosed |
| US-6620939-B2 | Reacting phenol and acetone in the presence of acid catalysts or promoters such as 2-(3'-tert-butylthiopropylthioethyl)-pyridine on catalyst supports, to form isopropylidenediphenol; stereospecific | GENERAL ELECTRIC COMPANY | 2003-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050090697-A1 | Method for producing bisphenol catalysts and bisphenols | GSTP1, PCBP1, GSTA2 | RAB9A 4540/4885NPC1 4565/4885BCHE 2726/4885 |
| US-20050090696-A1 | Method for producing bisphenol catalysts and bisphenols | GSTP1, PCBP1, GSTA2 | RAB9A 4540/4885NPC1 4565/4885BCHE 2726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.